55Co-EDTA for renal imaging using positron emission tomography (PET): A feasibility study

Nuclear Medicine and Biology

Volumn 27, Issue 1, 2000, Pages 77-81

  Goethals, Patrick ^a,b   Volkaert, Anneke ^a,b   Vandewielle, Christof ^c   Dierckx, Rudy ^c   Lameire, Norbert ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c Dept Radiother Nucl M ^*  (Belgium)

Author keywords

55Co EDTA; Glomerular filtration rate; Kidney function; Total plasma clearance

Indexed keywords

CHROMIUM 51; COBALT; COBALT EDETATE; CHELATING AGENT; CHROMIUM; DIAGNOSTIC AGENT; EDETIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; GLOMERULUS FILTRATION RATE; KIDNEY DISEASE; KIDNEY SCINTISCANNING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; URINARY EXCRETION; ANIMAL; BLADDER; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; FEASIBILITY STUDY; HEART MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER; METABOLIC CLEARANCE RATE; METABOLISM; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; CHELATING AGENTS; CHROMIUM RADIOISOTOPES; COBALT RADIOISOTOPES; EDETIC ACID; FEASIBILITY STUDIES; GLOMERULAR FILTRATION RATE; INJECTIONS, INTRAVENOUS; KIDNEY; LIVER; MALE; METABOLIC CLEARANCE RATE; MYOCARDIUM; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; URINARY BLADDER;

EID: 0033625015     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00077-3     Document Type: Article

References (13)

1. Blaufox M. D., Aurell M. A., Bubeck B., Fommei E. F., Piepsz A., Russell C., Taylor A., Thomsen H. S., Volterrani D. (1996) Report of the Radionuclides in Nephrourology Committee on renal clearance. J. Nucl. Med. 37, 1883-1890.
2. Buxton D. B., Schwaiger M., Nguyen A., Phelps M. E., Schelbert H. R. (1988) Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ. Res. 63, 628-634.
3. Chantler C., Garnett E.S., Parsons V., Veall N. Glomerular filtration rate measurement in man by the single injection method using. Clin. Sci. 37:1969;169-180.
4. Chen B., Germano G., Huang S. C., Hawkins R. A., Hansen H. W., Robert M. J., Buxton D. B., Schelbert H. R., Kurtz I., Phelps M. E. (1992) A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. J. Am. Soc. Nephrol. 3, 1295-1306.
5. Garnett E.S., Parsons V., Veall N. Measurement of glomerular filtration rate in man using Cr51 edetic acid complexes. Lancet. I:1967;818-819.
6. Giese J., Rossing N. Renal inulin clearance versus total plasma clearance of Cr51-EDTA. Scand. J. Clin. Lab. Invest. 23:1969;301-305.
7. 11C]thymidine in Wistar rats. J. Nucl. Med. 40:1999;491-496.
8. Jones T. The imaging science of positron emission tomography. Eur. J. Nucl. Med. 23:1996;807-813.
9. Killion D., Nittzsche E., Choi Y., Schelbert H., Rosenthal J.T. Positron emission tomography A new method for determination of renal function . J. Urol. 150:1993;1064-1068.
10. Lagunas-Solar M.C., Jungerman J.A. Cyclotron production of carrier-free cobalt-55, a new positron-emitting label for bleomycin. Int. J. Appl. Radiat. Isot. 30:1979;25-32.
11. Mamoun A. H., Södersten P. and Bergström J. Ingestive and sexual behaviour and concentration of monoamines and amino acids in the cerebrospinal fluid in chronic uraemic rats. (submitted).
12. Sharma H., Zweit J., Smith A.M., Downey S. Production of cobalt-55, a short-lived, positron emitting radiolabel for Bleomycin. Appl. Radiat. Isot. 37:1986;105-109.
13. Shreve P., Chiao P.C., Humes H.D., Schwaiger M., Gross M.D. Carbon-11-Acetate PET imaging in renal disease. J. Nucl. Med. 36:1995;1595-1601.